PD-L2 is a negative regulator of T-cell activation. PD-L2 can bind to PD-1, which mediates inhibitory signals from the APC. However, it has been suggested that PD-L2 can act to stimulate an immunogenic response through an alternative receptor from PD-1.
ProSci’s monoclonal immune checkpoint antibodies made to improve in vitro studies. Unlike antibodies developed using proteins made in yeast or bacteria, these PD-L2 antibodies are developed with antigens expressed in mammalian cell lines, giving the most native post-translational modifications to the protein. They are guaranteed to work for their tested applications.
Sets consist of 20µg aliquots of several mouse monoclonal antibodies with different binding features allowing for selection of the best clone for your application.
ProSci’s Risk-Free PD-L2 antibodies are rigorously tested and guaranteed to work for their designated applications. PD-L2 antibodies were raised against the extracellular domain of human PD-L2.
KEY:
| Cat. No. | Product Type | Source |
|---|---|---|
| RF16020-01 | Recombinant Protein | HEK293 |
| RF10001-06 | Positive Control (Cell Lysate) | Raji |
| RF10001-04 | Positive Control (Tissue Lysate) | Human Tonsil |
| RF10002-04 | Positive Control (Cell Slides) | Raji |
| RF10002-02 | Negative Control (Cell Slides) | HEK293 |
| Cat. No. | Name | Host | Clonality | Applications |
|---|---|---|---|---|
| 4063 | PD-L2 Antibody | Rabbit | Polyclonal | ELISA, IF, IHC-P, WB |
For additional information on PD-1, visit
